AP

Arpita Pragnesh Agrawal

Active Director Director DIN 09428508
DIN 09428508 First appointment Dec 2021 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Arpita Pragnesh Agrawal

Data last updated:

Arpita Pragnesh Agrawal is a Director at Aristokest Drugs And Chemicals Private Limited (since 2021). The company operates in Chemicals.

DIN 09428508
Primary Designation Director
Industry Chemicals
First Appointment 08 Dec 2021
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director08 Dec 20212021Active

Board colleagues of Arpita Pragnesh Agrawal

Directorship timeline

Open interactive timeline →
Aristokest Drugs And Chemicals Private Limited
Premium access

Shareholding and investment profile for Arpita Pragnesh Agrawal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Arpita Pragnesh Agrawal

Arpita Pragnesh Agrawal currently holds 1 directorship: Aristokest Drugs And Chemicals Private Limited (Director, since 08 Dec 2021).

Arpita Pragnesh Agrawal was first appointed on 08 Dec 2021 as Director at Aristokest Drugs And Chemicals Private Limited.

The current boards of Arpita Pragnesh Agrawal's companies include Pragnesh Dineshchandra Agrawal (Aristokest Drugs And Chemicals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available